Goldman Sachs fined for gun-jumping in Biocon investment by Indian watchdog
Goldman Sachs was penalized for "gun-jumping" after having failed to notify the Indian antitrust watchdog of its investment in Biocon Biologics. The Competition Commission of India imposed a fine of 4...To view the full article, register now.
Already a subscriber? Click here to view full article